eh1301321_13da1-safestitch.htm
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
SCHEDULE 13D/A
 
Under the Securities Exchange Act of 1934
(Amendment No. 1)*


 
TransEnterix, Inc.
(Name of Issuer)
 
Common Stock, $0.001 par value per share
(Title of Class of Securities)
 
78645Y102
(CUSIP Number)
 
Aisling Capital
888 Seventh Avenue, 30th Floor
New York, NY 10106
(212) 651-6380
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
December 6, 2013
(Date of Event Which Requires Filing of This Statement)
 

 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
 
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 


 
 
 

 

 
CUSIP No. 78645Y102
 
SCHEDULE 13D/A
Page 2 of 10
 
 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Aisling Capital III, LP
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
36,490,260
8
SHARED VOTING POWER
 
-0-
9
SOLE DISPOSITIVE POWER
 
36,490,260
10
SHARED DISPOSITIVE POWER
 
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
36,490,260
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
15.0% (1)
 
14
TYPE OF REPORTING PERSON
 
PN
 
 

(1)
The calculation of the percentage is based on an aggregate of 244,052,759 shares of Common Stock deemed issued and outstanding, consisting of (i) 168,355,715 shares of the Issuer’s Common Stock outstanding as of October 29, 2013 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s Schedule 14C filed with the Securities Exchange Commission (the “SEC”) on November 15, 2013, and (ii) 75,697,044 shares of Common Stock issued upon the automatic conversion of 7,569,704.4 shares of Series B Preferred Stock effective December 6, 2013.
 
 
 
 

 
 
CUSIP No. 78645Y102
 
SCHEDULE 13D/A
Page 3 of 10

 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Aisling Capital Partners III, LP
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
36,490,260
8
SHARED VOTING POWER
 
-0-
9
SOLE DISPOSITIVE POWER
 
36,490,260
10
SHARED DISPOSITIVE POWER
 
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
36,490,260
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
15.0% (1)
 
14
TYPE OF REPORTING PERSON
 
PN
 
 

(1)
The calculation of the percentage is based on an aggregate of 244,052,759 shares of Common Stock deemed issued and outstanding, consisting of (i) 168,355,715 shares of the Issuer’s Common Stock outstanding as of October 29, 2013 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s Schedule 14C filed with the Securities Exchange Commission (the “SEC”) on November 15, 2013, and (ii) 75,697,044 shares of Common Stock issued upon the automatic conversion of 7,569,704.4 shares of Series B Preferred Stock effective December 6, 2013.
 
 
 
 
 
 

 
 
 
CUSIP No. 78645Y102
 
SCHEDULE 13D/A
Page 4 of 10

 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Aisling Capital Partners III LLC
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
36,490,260
8
SHARED VOTING POWER
 
-0-
9
SOLE DISPOSITIVE POWER
 
36,490,260
10
SHARED DISPOSITIVE POWER
 
-0-
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
36,490,260
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
15.0% (1)
 
14
TYPE OF REPORTING PERSON
 
OO
 
 

(1)
The calculation of the percentage is based on an aggregate of 244,052,759 shares of Common Stock deemed issued and outstanding, consisting of (i) 168,355,715 shares of the Issuer’s Common Stock outstanding as of October 29, 2013 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s Schedule 14C filed with the Securities Exchange Commission (the “SEC”) on November 15, 2013, and (ii) 75,697,044 shares of Common Stock issued upon the automatic conversion of 7,569,704.4 shares of Series B Preferred Stock effective December 6, 2013.
 
 
 
 
 

 
 
CUSIP No. 78645Y102
 
SCHEDULE 13D/A
Page 5 of 10

  
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Steve Elms
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
36,490,260
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
36,490,260
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
36,490,260
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
15.0% (1)
 
14
TYPE OF REPORTING PERSON
 
IN
 
 

(1)
The calculation of the percentage is based on an aggregate of 244,052,759 shares of Common Stock deemed issued and outstanding, consisting of (i) 168,355,715 shares of the Issuer’s Common Stock outstanding as of October 29, 2013 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s Schedule 14C filed with the Securities Exchange Commission (the “SEC”) on November 15, 2013, and (ii) 75,697,044 shares of Common Stock issued upon the automatic conversion of 7,569,704.4 shares of Series B Preferred Stock effective December 6, 2013.
 
 
 
 

 
 
 
CUSIP No. 78645Y102
 
SCHEDULE 13D/A
Page 6 of 10

 
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Dennis Purcell
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
36,490,260
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
36,490,260
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
36,490,260
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
15.0% (1)
 
14
TYPE OF REPORTING PERSON
 
IN
 
 

(1)
The calculation of the percentage is based on an aggregate of 244,052,759 shares of Common Stock deemed issued and outstanding, consisting of (i) 168,355,715 shares of the Issuer’s Common Stock outstanding as of October 29, 2013 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s Schedule 14C filed with the Securities Exchange Commission (the “SEC”) on November 15, 2013, and (ii) 75,697,044 shares of Common Stock issued upon the automatic conversion of 7,569,704.4 shares of Series B Preferred Stock effective December 6, 2013.
 
 
 
 

 
 
 
CUSIP No. 78645Y102
 
SCHEDULE 13D/A
Page 7 of 10

  
1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Andrew Schiff
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
 
(a)  o
(b)  x
3
SEC USE ONLY
 
 
 
4
SOURCE OF FUNDS
 
OO
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
 
 
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
 
-0-
8
SHARED VOTING POWER
 
36,490,260
9
SOLE DISPOSITIVE POWER
 
-0-
10
SHARED DISPOSITIVE POWER
 
36,490,260
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
36,490,260
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
 
 
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
15.0% (1)
 
14
TYPE OF REPORTING PERSON
 
IN
 
 

(1)
The calculation of the percentage is based on an aggregate of 244,052,759 shares of Common Stock deemed issued and outstanding, consisting of (i) 168,355,715 shares of the Issuer’s Common Stock outstanding as of October 29, 2013 (but excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock), as reported in the Issuer’s Schedule 14C filed with the Securities Exchange Commission (the “SEC”) on November 15, 2013, and (ii) 75,697,044 shares of Common Stock issued upon the automatic conversion of 7,569,704.4 shares of Series B Preferred Stock effective December 6, 2013.
 
 
 
 

 
 
CUSIP No. 78645Y102
 
SCHEDULE 13D/A
Page 8 of 10

 
Item 1.
Security and Issuer.
 
This Amendment No.1 to Schedule 13D (this “Statement”) amends and supplements the Schedule 13D (Schedule 13D) as previously filed by the undersigned Reporting Persons (as defined below) with respect to common stock, par value $0.01 per share (the “Common Stock”) with respect to the Common Stock, $0.001 par value (the “Shares”), of TransEnterix, Inc. (f/k/a SafeStitch Medical, Inc. and Cellular Technical Services Company, Inc.), a Delaware corporation (the “Issuer”). The principal executive office of the Issuer is located at 635 Davis Drive, Suite 300, Durham, North Carolina 27713.
 
Item 2.
Identity and Background.

No material change.

Item 3.
Source and Amount of Funds or Other Consideration.
 
No material change.
 
Item 4.
Purpose of Transaction.

No material change.

Item 5.
Interest in Securities of the Issuer.
 
Items 5(a), (b) and (c)  are amended and restated in their entirety as follows:
 
“(a)  To the best knowledge of the Reporting Persons, as of October 29, 2013, there were 168,355,715  Shares issued and outstanding (excluding any options, warrants, or other rights to acquire the Issuer’s Common Stock and 7,569,704.4 shares of Series B Preferred Stock issued and outstanding, as reported in the Issuer’s Schedule 14C filed with the SEC on November 15, 2013, of which 1,240,176.4 Series B Shares were beneficially owned by the Reporting Persons.  On December 6, 2013, all outstanding Series B Shares were automatically converted into 75,697,044 Shares pursuant to the terms of Series B Preferred Stock on a 1 to 10 basis (such conversion, the “Conversion”) upon the filing of an amendment to the Issuer’s Certificate of Incorporation.  As part of the Conversion, 1,240,176.4 Series B Shares beneficially owned by the Reporting Persons were converted into 12,401,764 shares of Common Stock.  As a result, the Reporting Persons beneficially own in the aggregate 36,490,260 Shares, representing 15.0% of the total outstanding Shares giving effect to the Conversion.
 
Aisling Capital III, LP
Aisling Capital Partners III, LP
Aisling Capital Partners III LLC
  
Common
Stock
 
Amount beneficially owned:
  
 
36,490,260
  
Percent of class:
  
     
(i) Sole voting power
  
 
15.0
(ii) Shared voting power
  
 
0
  
(iii) Sole dispositive power
  
 
15.0
(iv) Shared dispositive power
  
 
0
  
 
 
 

 
 
 
CUSIP No. 78645Y102
 
SCHEDULE 13D/A
Page 9 of 10

 
Steve Elms
Dennis Purcell
Andrew Schiff
  
Common
Stock
 
Amount beneficially owned:
  
 
36,490,260
  
Percent of class:
  
     
(i) Sole voting power
  
 
0
  
(ii) Shared voting power
  
 
15.0
(iii) Sole dispositive power
  
 
0
  
(iv) Shared dispositive power
  
 
15.0
 
(b)
 
(i) Each of Aisling, Aisling Partners and Aisling Partners GP may be deemed to have sole power to direct the voting and disposition of the 36,490,260 Shares that may be deemed to be beneficially owned by the Reporting Persons.
 
Aisling Capital III, LP
Aisling Capital Partners III, LP
Aisling Capital Partners III LLC
  
Common
Stock
 
Amount beneficially owned:
  
 
36,490,260
  
Percent of class:
  
     
(i) Sole voting power
  
 
15.0
(ii) Shared voting power
  
 
0
  
(iii) Sole dispositive power
  
 
15.0
(iv) Shared dispositive power
  
 
0
  
 
(ii) By virtue of the relationships between and among the Reporting Persons described in Item 2 of this Schedule 13D, each of the Messrs. Elms, Purcell and Schiff may be deemed to share the power to direct the voting and disposition of the 36,490,260 Shares beneficially owned by the Reporting Persons.
 
Steve Elms
Dennis Purcell
Andrew Schiff
  
Common
Stock
 
Amount beneficially owned:
  
 
36,490,260
  
Percent of class:
  
     
(i) Sole voting power
  
 
0
  
(ii) Shared voting power
  
 
15.0
(iii) Sole dispositive power
  
 
0
  
(iv) Shared dispositive power
  
 
15.0
 
(c) Recent Transactions. 1,240,176.4 shares of Series B Preferred Stock held by Aisling were automatically converted into 12,401,764 Shares effective December 6, 2013 in the Conversion.”
 
Item 6.
Contract, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
 
No material change.
 
Item 7.
Material to Be Filed as Exhibits.
 
The following documents are filed as exhibits hereto:
 
Exhibit 1:
  
Statement Appointing Designated Filer dated as of September 13, 2013, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (incorporated herein by reference to Exhibit 1 to Schedule 13D filed by the Reporting Persons on September 13, 2013).
 
 
 
 

 

 
CUSIP No. 78645Y102
 
SCHEDULE 13D/A
Page 10 of 10

 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Date: December 10, 2013
 
AISLING CAPITAL III, LP
 
     
By:
Aisling Capital Partners III, LP
 
 
General Partner
 
     
By:
Aisling Capital Partners III LLC
 
 
General Partner
 
     
By:
/s/ Dennis Purcell
 
 
Name: Dennis Purcell
 
 
Title: Managing Member
 
     
     
AISLING CAPITAL PARTNERS III, LP
 
     
By:
Aisling Capital Partners III LLC
 
 
General Partner
 
     
     
By:
/s/ Dennis Purcell
 
 
Name: Dennis Purcell
 
 
Title: Managing Member
 
     
     
AISLING CAPITAL PARTNERS III LLC
 
     
     
By:
/s/ Dennis Purcell
 
 
Name: Dennis Purcell
 
 
Title: Managing Member
 
     
     
By:
/s/ Steve Elms
 
 
Steve Elms
 
     
     
By:
/s/ Dennis Purcell
 
 
Dennis Purcell
 
     
     
By:
/s/ Andrew Schiff
 
 
Andrew Schiff